Guoshu C. Bi

No. 180 Fenglin Road
Xuhui, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications

A tumor-derived lactate/ENO1 lactylation feedback loop facilitates osimertinib resistance of lung adenocarcinoma.

A tumor-derived lactate/ENO1 lactylation feedback loop facilitates osimertinib resistance of lung adenocarcinoma.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: November 20, 2025

Cone-beam CT-guided thermal ablation vs video-assisted thoracic surgery in treatment of non-small-cell lung cancer: A propensity score matching analysis.

Cone-beam CT-guided thermal ablation vs video-assisted thoracic surgery in treatment of non-small-cell lung cancer: A propensity score matching analysis.

Journal: Journal of cancer research and therapeutics
Published: October 24, 2025

MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosis.

MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosis.

Journal: Respiratory research
Published: October 11, 2025

Unveiling DEFB1 as a novel driver and promising therapeutic target in lung adenocarcinoma.

Unveiling DEFB1 as a novel driver and promising therapeutic target in lung adenocarcinoma.

Journal: Cell death & disease
Published: August 25, 2025

Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma.

Targeting inosine metabolism to enhance EGFR-targeted therapy in lung adenocarcinoma.

Journal: Cancer letters
Published: August 01, 2025

CD24 is a promising immunotherapeutic target for enhancing efficacy of third-generation EGFR-TKIs on EGFR-mutated lung cancer.

CD24 is a promising immunotherapeutic target for enhancing efficacy of third-generation EGFR-TKIs on EGFR-mutated lung cancer.

Journal: Cancer communications (London, England)
Published: March 14, 2025

Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status.

Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status.

Journal: Nature communications
Published: January 31, 2025

NDRG1-Driven Lactate Accumulation Promotes Lung Adenocarcinoma Progression Through the Induction of an Immunosuppressive Microenvironment.

NDRG1-Driven Lactate Accumulation Promotes Lung Adenocarcinoma Progression Through the Induction of an Immunosuppressive Microenvironment.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 20, 2025

KLF13 promotes ferroptosis and chemosensitivity in lung adenocarcinoma.

KLF13 promotes ferroptosis and chemosensitivity in lung adenocarcinoma.

Journal: BMC biology
Published: January 17, 2025

Transcription factor ZNF266 suppresses cancer progression by modulating CA9-mediated intracellular pH alteration in lung adenocarcinoma.

Transcription factor ZNF266 suppresses cancer progression by modulating CA9-mediated intracellular pH alteration in lung adenocarcinoma.

Journal: Respiratory research
Published: January 11, 2025

Ferroptosis-induced SUMO2 lactylation counteracts ferroptosis by enhancing ACSL4 degradation in lung adenocarcinoma.

Ferroptosis-induced SUMO2 lactylation counteracts ferroptosis by enhancing ACSL4 degradation in lung adenocarcinoma.

Journal: Cell discovery
Published: December 31, 2024

Sarcosine sensitizes lung adenocarcinoma to chemotherapy by dual activation of ferroptosis via PDK4/PDHA1 signaling and NMDAR-mediated iron export.

Sarcosine sensitizes lung adenocarcinoma to chemotherapy by dual activation of ferroptosis via PDK4/PDHA1 signaling and NMDAR-mediated iron export.

Journal: Experimental hematology & oncology
Published: December 30, 2024
Showing 1-12 of 78

Last Updated: 09/26/2026